United States: Substitute Claims Upheld As Prior Art Is Inapplicable To Pharmaceutical Compositions - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Mondaq

31 Oct 2023 0 shares 1 views

United States: Substitute Claims Upheld As Prior Art Is Inapplicable To Pharmaceutical Compositions - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Mondaq

Published 31 Oct 2023

In Hope Medical Enterprises Inc., v. Fennec Pharmaceuticals Inc.,[i] the Board's Final Written Decision (FWD) found that Petitioner had not demonstrated that claims to a method for synthesizing...

Full Article

United States: Fraud Committed In Seeking Incontestability Status Is Not A Basis For Cancelling Trademark Registration - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Mondaq 31 Oct 2023

In Great Concepts, LLC v. Chutter, Inc., No. 22-1212 (Fed. Cir. Oct. 18, 2023), the Federal Circuit reversed the Trademark Trial..

More coverage

United States: Characterization Of Reference As Primary Or Secondary Has No Effect On The Obviousness Analysis - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Mondaq 23 Oct 2023

In Schwendimann v. Neenah, Inc., No. 22-1333 (Fed. Cir. Oct. 6, 2023), the Federal Circuit affirmed the Patent Trial and Appeal..

United States: Substitute Claims Upheld As Prior Art Is Inapplicable To Pharmaceutical Compositions - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

United States: Substitute Claims Upheld As Prior Art Is Inapplicable To Pharmaceutical Compositions - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

You might like

Related news coverage

United States: Fraud Committed In Seeking Incontestability Status Is Not A Basis For Cancelling Trademark Registration - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Advertisement

More coverage

United States: Characterization Of Reference As Primary Or Secondary Has No Effect On The Obviousness Analysis - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP